1030613-34-3

Basic information

• Product Name: 3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-4,5-dihydroisoxazole-5-carboxylic acid amide
• Synonyms: 3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-4,5-dihydroisoxazole-5-carboxylic acid amide
• CAS NO: 1030613-34-3
• Molecular Weight: 386.221
• Mol File: 1030613-34-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-4,5-dihydroisoxazole-5-carboxylic acid amide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-4,5-dihydroisoxazole-5-carboxylic acid amide(1030613-34-3)
• EPA Substance Registry System: 3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-4,5-dihydroisoxazole-5-carboxylic acid amide(1030613-34-3)

Safety Data

• Hazardous Substances Data: 1030613-34-3(Hazardous Substances Data)

Upstream product

• 348-57-2 2,4-difluorobromobenzene 
• 5382-16-1 4-HYDROXYPIPERIDINE 
• 916971-27-2 4-(2-bromo-5-fluorophenoxy)piperidine 
• 1030613-69-4 3-bromo-4,5-dihydro-isoxazole-5-carboxylic acid amide 

Downstream Products

• 1030613-36-5 3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]isoxazole-5-carboxylic acid amide 
• 1030613-38-7 3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]isoxazole-5-carbonitrile 
• 1030612-90-8 2-(5-{3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-1,2-oxazol-5-yl}-2H-1,2,3,4-tetrazol-2-yl)acetic acid 
• 1030613-40-1 4-(2-bromo-5-fluorophenoxy)-1-[5-(2H-tetrazol-5-yl)isoxazol-3-yl]piperidine 
• 1329632-66-7 (5-{3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-isoxazol-5-yl}tetrazol-2-yl)-acetic acid tert-butyl ester 

Relevant articles and documents

Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase

Azacycloalkane derivatives of structural formula I are selective inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD1) relative to other known stearoyl-coenzyme A desaturases. The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, such as atherosclerosis; obesity; diabetes; neurological disease; metabolic syndrome; insulin resistance; and liver steatosis.